Intestinal Research

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study

Akihiro Koga, Toshiyuki Matsui, Noritaka Takatsu, Yasumichi Takada, Masahiro Kishi, Yutaka Yano, Takahiro Beppu, Yoichiro Ono, Kazeo Ninomiya, Fumihito Hirai, Takashi Nagahama, Takashi Hisabe, Yasuhiro Takaki, Kenshi Yao, Hirotsugu Imaeda, Akira Andoh

Intest Res. 2018;16(2):223-232. Published online April 30, 2018
DOI: https://doi.org/10.5217/ir.2018.16.2.223

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study

Intestinal Research. 2018;16(2):223

Link1 Link2 Link3

Mo1263 CRP, but Not CDAI is Associated With Enterocolonic Mucosal Healing in Crohn's Disease Treated With Infliximab; A Single Center Cohort Study

Atsuo Maemoto, Shigeru Furukawa, Fumika Orii, Toshifumi Ashida

Gastrointestinal Endoscopy. 2012;75(4):AB369

Link1 Link2

W1279 Mucosal Healing With Methotrexate in Crohn's Disease: A Prospective Comparative Study With Azathioprine and Infliximab

David Laharie, Armel Reffet, Edouard Chabrun, Clement Subtil, Sylvie Razaire, Victor de Ledinghen

Gastroenterology. 2010;138(5):S-689-S-690

Link1 Link2

405 High Infliximab Trough Levels are Associated With Mucosal Healing in Crohn's Disease

Wouter Van Moerkercke, Chloé Ackaert, Griet Compernolle, Matthias Jürgens, Isabelle Cleynen, Gert A. Van Assche, Paul J. Rutgeerts, Ann Gils, Severine Vermeire

Gastroenterology. 2010;138(5):S-60

Link1 Link2

Mucosal healing with methotrexate in Crohn’s disease: a prospective comparative study with azathioprine and infliximab

D. Laharie, A. Reffet, G. Belleannée, E. Chabrun, C. Subtil, S. Razaire, M. Capdepont, V. de Lédinghen

Alimentary Pharmacology & Therapeutics. 2011;33(6):714-721

Link1 Link2

Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn’s Disease Patients Treated With Combined Immunosuppressive Therapy

Ben Kang, So Yoon Choi, Young Ok Choi, Min-ji Kim, Kyunga Kim, Ji-Hyuk Lee, Yon Ho Choe

Journal of Crohn's and Colitis. 2018;12(6):644-652

Link1

Infliximab Trough Levels Are Associated With Mucosal Healing During Maintenance Treatment With Infliximab in Paediatric Crohn’s Disease

Ben Kang, So Yoon Choi, Young Ok Choi, Soo-Youn Lee, Sun-Young Baek, Insuk Sohn, Byung-Ho Choe, Hae Jeong Lee, Yon Ho Choe

Journal of Crohn's and Colitis. 2018;13(2):189-197

Link1

P818 Polymorphisms in C1orf106, IL1RN, IL10 are associated with postinduction infliximab trough level in Crohn's disease patients

J Tang, C Zhang, X Wang, X Gao

Journal of Crohn's and Colitis. 2019;13(Supplement_1):S531-S532

Link1

Mo1413 Improved Mucosal Healing During Infliximab Maintenance Therapy Initiated Following Resection of Active Lesions in Crohn's Disease Patients

Yasuo Suzuki, Akihiro Yamada

Gastrointestinal Endoscopy. 2012;75(4):AB417

Link1 Link2

Tu1150 Association of Serum Infliximab and Antibodies to Infliximab to Long-Term Clinical Outcome and Mucosal Healing in Crohn's Disease

Ofer Ben-Bassat, Anna Romanova, Anna Iacono, Sue P. Irwin, Gordon R. Greenberg

Gastroenterology. 2013;144(5):S-775

Link1 Link2